Find insight on Regis Healthcare, CSPC Pharmaceutical and more in the latest Market Talks covering the health care sector.

AstraZeneca has signed an AI-led research agreement with China’s CSPC Pharmaceutical Group worth up to $5.3 billion, which ...

上周五，英国制药巨头阿斯利康（AstraZeneca, NASDAQ:AZN）宣布与中国石药集团（CSPC Pharmaceutical）达成一项潜在价值高达53.3亿美元的战略研究合作，旨在利用人工智能（AI）开发针对多种慢性疾病的新型口服疗法。

Jeremy Skillington, CEO of LSE-listed Poolbeg Pharma, which has programmes targeting areas of high unmet medical need, ...